中文版 | English

在结果中检索

CASIA OpenIR

浏览/检索结果: 共5条，第1-5条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Noninvasive Imaging for Assessment of the Efficacy of Therapeutic Agents for Hepatocellular Carcinoma 期刊论文
Molecular Imaging and Biology, 2019, 期号: 10.1007/s11307-019-01431-5, 页码: 1-14
作者:  Liang, Qian;  Kong, Lingxin;  Zhu, Xu;  Du, Yang;  Tian, Jie
浏览  |  Adobe PDF(3951Kb)  |  收藏  |  浏览/下载：311/109  |  提交时间：2020/06/03
Hepatocellular carcinoma  Molecular imaging  Preclinical drug evaluation  Clinical trial  Therapeutics  
Selection Between Liver Resection Versus Transarterial Chemoembolization in Hepatocellular Carcinoma: A Multicenter Study 期刊论文
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2019, 卷号: 10, 页码: 12
作者:  Fu, Sirui;  Wei, Jingwei;  Zhang, Jie;  Dong, Di;  Song, Jiangdian;  Li, Yong;  Duan, Chongyang;  Zhang, Shuaitong;  Li, Xiaoqun;  Gu, Dongsheng;  Chen, Xudong;  Hao, Xiaohan;  He, Xiaofeng;  Yan, Jianfeng;  Liu, Zhenyu;  Tian, Jie;  Lu, Ligong
收藏  |  浏览/下载：296/0  |  提交时间：2019/12/16
Antitumorigenic and antiangiogenic efficacy of apatinib in liver cancer evaluated by multimodality molecular imaging 期刊论文
EXPERIMENTAL AND MOLECULAR MEDICINE, 2019, 卷号: 51, 页码: 11
作者:  Liang, Qian;  Kong, Lingxin;  Du, Yang;  Zhu, Xu;  Tian, Jie
Adobe PDF(2847Kb)  |  收藏  |  浏览/下载：443/103  |  提交时间：2019/12/16
Preclinical comparison of regorafenib and sorafenib efficacy for hepatocellular carcinoma using multimodality molecular imaging 期刊论文
CANCER LETTERS, 2019, 卷号: 453, 页码: 74-83
作者:  Liu, Shengnan;  Du, Yang;  Ma, He;  Liang, Qian;  Zhu, Xu;  Tian, Jie
收藏  |  浏览/下载：256/0  |  提交时间：2019/07/12
Hepatocellular carcinoma  Regorafenib  Sorafenib  Molecular imaging  Therapeutic effects  
Sorafenib-loaded polymeric micelles as passive targeting therapeutic agents for hepatocellular carcinoma therapy 期刊论文
NANOMEDICINE, 2018, 卷号: 13, 期号: 9, 页码: 1009-1023
作者:  Su, Yanhong;  Wang, Kun;  Li, Yong;  Song, Wenjing;  Xin, Yongjie;  Zhao, Wei;  Tian, Jie;  Ren, Li;  Lu, Ligong
浏览  |  Adobe PDF(25127Kb)  |  收藏  |  浏览/下载：243/44  |  提交时间：2019/09/26
drug delivery  hepatocellular carcinoma  micelles  sorafenib  therapy